Edwards Lifesciences Corp EW

Morningstar Rating
$92.39 −0.65 (0.70%)
View Full Chart

Company Report

Price vs Fair Value

EW is trading at a LOCK|XlZg^R premium.
Price
$93.05
Fair Value
vz
Uncertainty
LOCK|z!
1-Star Price
LOCK|y.<g
5-Star Price
LOCK|.Fh
Economic Moat
LOCK|!<sJl
Capital Allocation
LOCK|%@r>%BxZ

Bulls Say, Bears Say

Bulls

Edwards' efforts to focus on efficiency and higher-margin products have paid off, as gross margins increased from 47% in 2000 to 78% in 2025.

Bears

Edwards' ambitions to diversify into minimally invasive medical technologies place the firm in direct competition with much larger competitors, such as Medtronic and Abbott, which can easily bid up prices for emerging technologies that Edwards couldn't match.

News

Trading Information

Previous Close Price
$93.05
Day Range
$92.2993.69
52-Week Range
$72.3096.27
Bid/Ask
$92.38 / $92.41
Shares Outstanding
576.40M
Market Cap
$53.24B
Volume/Avg
1M / 5M

Key Statistics

Price/Earnings (Normalized)
33.11
Price/Sales
8.31
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
2.25%

Company Profile

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Growth
Total Number of Employees
16,000

Competitors

Valuation

Metric
EW
ABT
MDT
Price/Earnings (Normalized)
33.1121.0716.59
Price/Book Value
5.053.752.35
Price/Sales
8.314.163.21
Price/Cash Flow
32.9317.7113.36
Price/Earnings
EW
ABT
MDT

Financial Strength

Metric
EW
ABT
MDT
Quick Ratio
3.450.971.36
Current Ratio
4.521.382.13
Interest Coverage
10.409.58
Quick Ratio
EW
ABT
MDT

Profitability

Metric
EW
ABT
MDT
Return on Assets (Normalized)
12.05%9.71%7.76%
Return on Equity (Normalized)
15.67%17.95%14.65%
Return on Invested Capital (Normalized)
13.78%13.03%9.93%
Return on Assets
EW
ABT
MDT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|d<J@d!LOCK|t&w$g$192B
Stryker Corp
SYK
LOCK|!fh>pW%LOCK|wK$133B
Medtronic PLC
MDT
LOCK|q!p>$@LOCK|ztFC$116B
Boston Scientific Corp
BSX
LOCK|!!>hzlLOCK|yNVJz$75B
DexCom Inc
DXCM
LOCK|MZn!>!LxLOCK|@TZ#%$34B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|B^!ldwLOCK|^D$33B
Koninklijke Philips NV ADR
PHG
LOCK|>H^LOCK|<T$26B
Steris PLC
STE
LOCK|!?!!F@LOCK|yLswg$23B
Zimmer Biomet Holdings Inc
ZBH
LOCK|yKyp<?LLOCK|@K$19B

Sponsor Center